Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Distamycin analogues with improved sequence-specific DNA binding activities

A Ciucci1, G Feriotto, C Mischiati

  • 1Menarini Ricerche Sud, Pomezia, Italy.

Biochemical Pharmacology
|October 18, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten.

Amino acids·2016
Same author

Efficacy, safety and acceptability of the new pen needle 33G × 4 mm. AGO 01 study.

Current medical research and opinion·2014
Same author

Studies on the chemistry of a glucoside a antibiotic from a Streptomyces sp.

Antibiotics & chemotherapy (Northfield, Ill.)·2014
Same author

Effect of stentgraft model on aneurysm shrinkage in 1,450 endovascular aortic repairs.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2013
Same author

Plaque debulking for femoro-popliteal occlusions: techniques and results.

The Journal of cardiovascular surgery·2013
Same author

Molecular cytogenetic analysis of human breast tumors: methylation pattern of the HLA-DRα gene.

Cytotechnology·2012
Same journal

The role of Piezo1 in skeletal muscle physiology and pathology: from mechanosensing to precision therapy.

Biochemical pharmacology·2026
Same journal

Notch signaling in anti-VEGF resistant arteriolar choroidal neovascularization.

Biochemical pharmacology·2026
Same journal

Methylated SNHG3 lncRNA counteracts PSMD4-inhibited angiogenesis by HnRNPA2B1 SUMOylation in peripheral arterial disease.

Biochemical pharmacology·2026
Same journal

The organelle-targeting duality of nanomaterials: physicochemical property-guided therapeutic effects and toxicological outcomes.

Biochemical pharmacology·2026
Same journal

The central role of endoplasmic reticulum stress in Parkinson's disease and targeted therapeutic strategies.

Biochemical pharmacology·2026
Same journal

Mechanisms involved in the regulation of carbohydrate and lipid metabolism by oleanane-type pentacyclic triterpenes.

Biochemical pharmacology·2026
See all related articles

Researchers modified distamycin to create new DNA-binding drugs. Certain modifications enhanced the drug's ability to displace proteins like OCT-1 from DNA, impacting gene transcription.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Biochemistry

Background:

  • Distamycin is a natural product known to bind DNA.
  • Sequence-specific DNA-protein interactions are crucial for gene regulation.
  • Understanding how small molecules can modulate these interactions is key for drug development.

Purpose of the Study:

  • To investigate novel chemical modifications of distamycin.
  • To assess the impact of these modifications on DNA-protein binding.
  • To develop distamycin analogues with improved DNA-binding and displacement properties.

Main Methods:

  • Electrophoretic mobility shift assay (EMSA) was used to evaluate DNA-protein binding.
  • Synthesis of novel distamycin analogues with specific chemical alterations.

Related Experiment Videos

  • In vitro transcription assays were performed to assess functional impact.

    • Main Results:

    • Novel distamycin analogues were identified with enhanced ability to displace octamer nuclear factors (e.g., OCT-1) from their DNA targets.
    • Specific modifications, such as reverting the formamido to a carboxyamido group or introducing a formimidoyl moiety, significantly improved displacing ability.
    • Other modifications, like altering pyrrole rings or amide bonds, resulted in similar or reduced activity.
    • These modifications influenced tissue-specific, octamer-dependent in vitro transcription.

    Conclusions:

    • Chemical modifications of distamycin can rationally design potent DNA-binding drugs.
    • Improved displacement of OCT-1 by modified distamycins directly impacts the function of octamer-containing promoters.
    • This study provides a framework for developing sequence-specific DNA-binding agents for therapeutic applications.